miR-33a levels in hepatic and serum after chronic HBV-induced fibrosis

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of gastroenterology

• Publication date

  2015-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00535-014-0986-3PMID 25155445
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells.

  2014cited by this paper
• MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein.

  2013cited by this paper
• Hepatic and serum levels of miR-122 after chronic HCV-induced fibrosis.

  2013cited by this paper
• MicroRNA genetic variations: association with type 2 diabetes

  2013cited by this paper
• MicroRNAs in liver disease

  2013cited by this paper
• Differential MicroRNA Expression Profiles in Peripheral Arterial Disease

  2013cited by this paper
• miR-133a mediates TGF-β-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis.

  2013cited by this paper
• Beyond secondary structure: primary-sequence determinants license pri-miRNA hairpins for processing.

  2013cited by this paper
• Treatment of HCV infection by targeting microRNA.

  2013cited by this paper
• A Regulatory Role for MicroRNA 33* in Controlling Lipid Metabolism Gene Expression

  2013cited by this paper
• Hepatitis B virus infection status is an independent risk factor for multiple myeloma patients after autologous hematopoietic stem cell transplantation

  2013cited by this paper
• Mir-33 regulates cell proliferation and cell cycle progression

  2012cited by this paper
• MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4.

  2012cited by this paper
• The potential of microRNAs in liver fibrosis.

  2012cited by this paper
• microRNA involvement in human cancer.

  2012cited by this paper
• microRNA biogenesis pathway as a therapeutic target for human disease and cancer.

  2012cited by this paper
• Induction of microRNA-214-5p in human and rodent liver fibrosis

  2012cited by this paper
• Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis

  2012cited by this paper
• MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis

  2012influential reference
• Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

  2012cited by this paper
• MicroRNA Epigenetics

  2011cited by this paper
• Biomarkers of liver fibrosis: What lies beneath the receiver operating characteristic curve?

  2011cited by this paper
• Inhibitory Smad7: emerging roles in health and disease.

  2011cited by this paper
• New role of microRNA: carcinogenesis and clinical application in cancer.

  2011cited by this paper
• Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

  2011cited by this paper
• Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

  2011cited by this paper
• Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis

  2011cited by this paper
• Circulating microRNAs in hepatitis B virus–infected patients

  2011cited by this paper
• miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling

  2011cited by this paper
• MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions.

  2011cited by this paper
• Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides

  2011cited by this paper
• Therapeutic targets in liver fibrosis.

  2011cited by this paper
• MiR-33 Contributes to the Regulation of Cholesterol Homeostasis

  2010cited by this paper
• Evolving challenges in hepatic fibrosis

  2010cited by this paper
• miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

  2010cited by this paper
• Human primary cultured hepatic stellate cells can be cryopreserved

  2010cited by this paper
• Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans

  2010cited by this paper
• Isolation and culture of primary hepatocytes from resected human liver tissue.

  2010cited by this paper
• Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: An analytical review

  2010cited by this paper
• MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis

  2010cited by this paper
• Regulation of TGF-β signaling by Smad7

  2009cited by this paper
• Vaccination against hepatitis B: the Chinese experience.

  2009cited by this paper
• Circulating microRNAs, potential biomarkers for drug-induced liver injury

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Micromanagement of the immune system by microRNAs

  2008cited by this paper
• Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage.

  2008cited by this paper
• Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice

  2008cited by this paper
• Small non-coding RNAs in animal development

  2008cited by this paper
• microRNA functions.

  2007cited by this paper
• Bone morphogenetic proteins: from developmental signals to tissue regeneration

  2007cited by this paper
• Liver fibrosis: from mechanisms to treatment.

  2007cited by this paper
• Targeting fibrosis in systemic sclerosis.

  2006cited by this paper
• Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets

  2006cited by this paper
• Isolation and culture of hepatic stellate cells.

  2005cited by this paper
• Smad7 in TGF-beta-mediated negative regulation of gut inflammation.

  2004cited by this paper
• Smad7 in TGF-β-mediated negative regulation of gut inflammation

  2004cited by this paper
• Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.

  2003cited by this paper
• Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats.

  2003cited by this paper
• Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

  2001cited by this paper
• Isolation and culture of rat hepatic stellate cells

  1998cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Classification of chronic hepatitis: Diagnosis, grading and staging

  1994cited by this paper

• The role of liver macrophages in viral liver pathogenesis

  2025cites this paper
• Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions

  2025cites this paper
• The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis

  2025cites this paper
• Differential DNA methylation landscape of miRNAs genes in mice liver fibrosis

  2024cites this paper
• Non-Coding RNAs as Potential Diagnostic/Prognostic Markers for Hepatocellular Carcinoma

  2024cites this paper
• The miR-3074/BMP7 axis regulates TGF-β-caused activation of hepatic stellate cells in vitro and CCl4-caused murine liver fibrosis in vivo

  2024cites this paper
• Potential role of microRNAs in personalized medicine against hepatitis: a futuristic approach

  2024cites this paper
• Insights into the impact of hepatitis B virus on hepatic stellate cell activation

  2023cites this paper
• A Review of miRNA Regulation in Japanese Encephalitis (JEV) Virus Infection.

  2023cites this paper
• Sex‐specific analysis of microRNA profiles in HBV‐associated cirrhosis by small RNA‐sequencing

  2022cites this paper
• Identification of miR-199a-5p, miR-214-3p and miR-99b-5p as Fibrosis-Specific Extracellular Biomarkers and Promoters of HSC Activation

  2021cites this paper
• CAPN2 acts as an indicator of hepatitis B virus to induce hepatic fibrosis

  2020cites this paper
• Expression of hepatic stellate cell activation-related genes in HBV-, HCV-, and nonalcoholic fatty liver disease-associated fibrosis

  2020cites this paper
• Serum miR-17 levels in patients with hepatitis B virus induced liver fibrosis.

  2020cites this paper
• Current perspectives on inhibitory SMAD7 in health and disease

  2020cites this paper
• High-fructose drinks affect microRNAs expression differently in lean and obese mice.

  2019cites this paper
• The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis

  2019cites this paper
• MicroRNA-202-5p functions as a tumor suppressor in colorectal carcinoma by directly targeting SMARCC1.

  2018cites this paper
• Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B

  2018cites this paper
• STAT1-mediated upregulation of lncRNA LINC00174 functions a ceRNA for miR-1910-3p to facilitate colorectal carcinoma progression through regulation of TAZ.

  2018cites this paper
• Role of MicroRNAs in Hepatic Fibrosis Progression

  2018cites this paper
• MicroRNA-33 a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma

  2017cites this paper
• Long non-coding RNA LOC100129148 functions as an oncogene in human nasopharyngeal carcinoma by targeting miR-539-5p

  2017cites this paper
• MicroRNAs‐mediated epithelial‐mesenchymal transition in fibrotic diseases

  2017cites this paper
• MicroRNA-33a promotes cell proliferation and inhibits apoptosis by targeting PPARα in human hepatocellular carcinoma.

  2017cites this paper
• MicroRNA-33a deficiency inhibits proliferation and fibrosis through inactivation of TGF-β/Smad pathway in human cardiac fibroblasts.

  2017cites this paper
• Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2

  2017cites this paper
• Expression Profiling of Cellular MicroRNA in Asymptomatic HBsAg Carriers and Chronic Hepatitis B Patients

  2017cites this paper
• TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis

  2016cites this paper
• MicroRNA-1275 suppresses cell growth, and retards G1/S transition in human nasopharyngeal carcinoma by down-regulation of HOXB5

  2016cites this paper
• Hepatitis B virus inhibits intrinsic RIG-I and RIG-G immune signaling via inducing miR146a

  2016cites this paper
• Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma

  2016cites this paper
• MicroRNA-346 facilitates cell growth and metastasis, and suppresses cell apoptosis in human non-small cell lung cancer by regulation of XPC/ERK/Snail/E-cadherin pathway

  2016cites this paper
• Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis

  2016cites this paper
• MicroRNAs Play Significant Roles in Pathogenesis of HBV-Related Diseases

  2016cites this paper
• Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice

  2016cites this paper
• MicroRNA-33a-5p Modulates Japanese Encephalitis Virus Replication by Targeting Eukaryotic Translation Elongation Factor 1A1

  2016cites this paper
• MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6.

  2016cites this paper
• The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells

  2016cites this paper
• Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis

  2016cites this paper
• MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7

  2015cites this paper
• Strategies to prevent and reverse liver fibrosis in humans and laboratory animals

  2015cites this paper
• MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes

  2015cites this paper
• MicroRNAs as Important Players in Host-hepatitis B Virus Interactions

  2015cites this paper